Dr Lincoln Tsang
is a partner at the firm. He is a former senior regulator, and advises clients in pharmaceuticals, biotechnology, medical devices, in vitro diagnostic devices, cosmetics, and food with particular emphasis on the intersection of the law and public policy. He represents clients on highly technical and precedent-setting regulatory, compliance and enforcement matters. By ministerial appointment, Lincoln Tsang has served as a Commissioner for the British Pharmacopoeia where he chairs the Commission’s Biological and Biotechnology Specialist Group and co-chairs the Nomenclature Committee as well as a non-executive director of the National Institute for Biological Standards and Control, and the Health Protection Agency.